Interestingly, a recent report also revealed that miR-15b holds the ability to negatively modulate targeted RECK in the HT1080 human fibrosarcoma cell line and Caco-2, a colon carcinoma cell line [26]. This evidence concerns the gene RECK and colon carcinoma.